e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.40p
   
  • Change Today:
    -0.35p
  • 52 Week High: 23.10p
  • 52 Week Low: 8.13p
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 4,821,033
  • Market Cap: £54.93m

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

e-therapeutics 03-May-2024 18:00 RNS
Result of General Meeting 29-Apr-2024 14:09 RNS
Proposed Fundraise of £28.9m and Cancellation 10-Apr-2024 07:00 RNS
Total Voting Rights 31-Jan-2024 16:30 RNS
Exercise of Options and Issue of Equity 24-Jan-2024 10:04 RNS
Business Update 16-Jan-2024 07:00 RNS
Director Dealing and Issue of Equity 09-Jan-2024 16:04 RNS
Update on OTCQX Market Listing 27-Dec-2023 07:00 RNS
Strategic RWE collaboration with Arcturis 02-Nov-2023 07:00 RNS
Interim results for the six months to 31 July 2023 26-Oct-2023 07:38 RNS
Notice of Interim Results 19-Oct-2023 09:54 RNS
Senior Management Update 20-Sep-2023 07:00 RNS
Exercise of Options and Issue of Equity 07-Sep-2023 11:47 RNS
Total Voting Rights 31-Jul-2023 16:30 RNS
Result of Annual General Meeting 18-Jul-2023 16:20 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.40p
Change Today -0.35p
% Change -3.59 %
52 Week High 23.10p
52 Week Low 8.13p
Volume 4,821,033
Shares Issued 584.34m
Market Cap £54.93m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average
60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average
Price Trend
60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average
5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average
Income Not Available
Growth
15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
12:33 1,834,972 @ 9.25p
16:10 25,000 @ 9.50p
15:45 54,184 @ 9.65p
15:45 54,184 @ 9.60p
15:45 54,184 @ 9.65p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page